Vivani Medical, Inc.

NASDAQ:VANI

Medical - Devices

Healthcare
$1.05 +1.30%

+$0.02 today

Market cap
$94.71M
Beta
3.29
P/E (TTM)
-3.5
EPS (TTM)
-$0.33
52W Low $0.92High $1.92

Volume 0.18M

Average 0.24M

VANI Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

Vivani Medical, Inc.NASDAQ: VANI

Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026

Selling, general & admin grows, but more slowly than its trailing trend

Q1 FY2026 selling, general & admin of $2.43M rose 3.7% year over year, behind the +9.5% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 11.3% from the prior quarter. Over 3 fiscal years it compounded at +20.6% a year.

Context

  • Selling, general & admin increased in 2 of the last 3 fiscal years.

What to watch

Whether selling, general & admin reaches the consensus estimate of $0 (-100.0%) for the fiscal year ending Dec 2026, a slowdown from the +5.6% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.43M+11.3% QoQ
Last fiscal yearDec 2025
$9.43M+5.6% YoY
LTMMar 2026
$9.52M+9.5% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.7%-100.0%-103.7 pp
1 year+5.6%-100.0%-105.6 pp
3-year CAGR+20.6%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
9.43M USD
Year-over-year change
+5.6%
4-year CAGR
+42.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How VANI compares with its peers on the latest reported figures

  • Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +9.5% is the 4th highest of 8, against a peer median of -2.2%.
  • Over three fiscal years its annual growth of +20.6% compares with a peer median of +2.5%.
VANI Competitors
Selling, General & Admin for VANI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RCELAVITA Medical, Inc.LTM Mar 2026$78.19M USD-14.1%+20.9%108.1%
HYPRHyperfine, Inc.LTM Mar 2026$26.33M USD-2.2%-17.3%171.8%
FONRFONAR CorporationLTM Mar 2026$21.42M USD+168.1%—20.3%
IMAImageneBio IncLTM Mar 2026$21.2M USD-9.1%-2.3%—
CRDLCardiol Therapeutics Inc.LTM Mar 2026CA$20.29M CAD-9.6%+7.3%—
MBOTMicrobot Medical Inc.LTM Mar 2026$9.71M USD+81.8%+13.9%9251.4%
VANIVivani Medical, Inc.LTM Mar 2026$9.52M USD+9.5%+20.6%—
ORMPOramed Pharmaceuticals Inc.LTM Mar 2026$8.48M USD+21.4%-17.7%—
Peer median (excluding VANI) —-2.2%+2.5%139.9%

Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00357K0424K
Gross Profit00(357K)0(424K)
Gross Margin—————
Research & Development11M14.17M16.97M15.75M18.13M
Selling, General & Admin2.32M5.37M10M8.93M9.43M
Operating Expenses13.32M21.24M26.61M24.68M27.13M
Depreciation & Amortization345K381K357K400K424K
EBITDA(12.43M)(19.16M)(25.3M)(23.09M)(26.19M)
EBITDA Margin—————
Operating Income(13.32M)(21.24M)(26.97M)(24.68M)(27.56M)
Operating Margin—————
Interest Income00000
Interest Expense00000
Other Income / Expenses550K7.35M1.31M1.19M947K
Income Before Tax(12.77M)(13.89M)(25.65M)(23.49M)(26.61M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(12.77M)(13.89M)(25.65M)(23.49M)(26.61M)
Net Margin—————
EPS (Basic)(0.33)(0.17)(0.50)(0.43)(0.43)
EPS (Diluted)(0.33)(0.17)(0.50)(0.43)(0.43)
Weighted Avg Shares36.25M38.24M50.85M54.98M62.39M
Weighted Avg Shares (Diluted)36.25M38.24M50.85M54.98M62.39M

Vivani Medical, Inc.

NASDAQ:VANI

Intrinsic Alpha fair value

Locked

Current Price

$1.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.